Altay Therapeutics
Oncology Therapeutics
Data updated Nov 20, 2026Money ledger: 7 records from 3 sourcesFiled 6Announced 1Full reportReport a mistake
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 20, 2026Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
- Legal name
- Altay Therapeutics, Inc.
- Headquarters
- San Carlos, United States
- Employees
- 3US Form 5500 (plan participants) · Dec 2025 · -40% in a year
- Website
- altaytherapeutics.com
These are the key facts about Altay Therapeutics on Alion as of Nov 20, 2026. Altay Therapeutics is headquartered in San Carlos, United States. It has raised $52.7M in 2 funding rounds. The latest round is Series A of $37M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 7 records →Altay Therapeutics has $52.7M paid in by investors, lenders and donors.
$52.7MPaid in
Money innewest first
$37MPaid
$15.7MPaid
$300kPaid
4 more records: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
People
3EmployeesUS Form 5500 (plan participants) · Dec 2025 · -40% in a year
Head countas filed and stated
Products
What the registers and the postings say about this employer.
Legal entity active
Altay Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| San Carlos United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Milestones
Oct 20
Raised a round Series A $37M · Pulse 2.0
May 15, 2024
Won a grant $300k · CORDIS
Jan 2020
Went through Y Combinator
Jul 2019
Website went live first capture in the Wayback Machine
Each milestone is dated by its source: registers, filings, the press
Newsroom
Oct 202026
News · Pulse 2.0
Altay Therapeutics has raised $37 million in Series A financing to advance DX5057, its investigational oral small-molecule therapy for facioscapulohumeral muscular dystrophy, or…
Sources: the outlets named on each headline, each story once
